E. Coakley

S. Dutta, E. Coakley, D. Cohen, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Phenotypic Susceptibility Assays for Human Immunodeficiency Virus Type 1

C. Petropoulos, N. Parkin, E. Coakley, 2009 .

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Eoin Coakley, Junyuan Xiong, Jordan J Feld, 2014, The New England journal of medicine.

A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism

Eoin Coakley, Monique Nijhuis, Colombe Chappey, 2007, PLoS medicine.

An interferon-free antiviral regimen for HCV after liver transplantation.

X. Forns, T. Pilot‐Matias, N. Terrault, 2014, The New England journal of medicine.

HLA-DR+ CD38+ CD4+ T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo

M. McCarter, D. N. Levy, E. Connick, 2011, Journal of Virology.

The influence of physico-chemical properties of fly ash and CKD on strength generation of high-volume fly ash concrete

M. Sadique, E. Coakley, 2016 .

CURVE is the Institutional Repository for Coventry University The influence of physico-chemical properties of fly ash and CKD on strength generation of high-volume fly ash concrete

M. Sadique, E. Coakley, 2016 .

Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations.

J. Coffin, C. Chappey, F. Maldarelli, 2010, Journal of virological methods.

HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization

R. Paredes, B. Clotet, J. Martinez-Picado, 2013, PloS one.

Combined Antiretroviral Therapy and Immune Pressure Lead to In Vivo HIV-1 Recombination With Ancestral Viral Genomes

B. Clotet, J. Martinez-Picado, T. Wrin, 2011, Journal of acquired immune deficiency syndromes.

HIV Replication Capacity Is an Independent Predictor of Disease Progression in Persons With Untreated Chronic HIV Infection

J. Kostman, M. Goetz, R. Luskin-Hawk, 2010, Journal of acquired immune deficiency syndromes.

Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.

Z. Su, J. Reeves, T. Wilkin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of Inferred CCR5- and CXCR4-Using HIV-1 Variants and Evolutionary Intermediates Using Ultra-Deep Pyrosequencing

E. Bunnik, H. Schuitemaker, P. Harrigan, 2011, PLoS pathogens.

The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.

C. Petropoulos, R. Kagan, E. Coakley, 2007, The Journal of infectious diseases.

Predictive value of HIV‐1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment‐experienced patients

E. Coakley, M. Holodniy, Y. Lie, 2012, HIV medicine.

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Eoin Coakley, Robert Gross, Wayne Greaves, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microstructure and Physical-Mechanical Characteristics of Treated Kaolin-Bentonite Mixture for Application in Compacted Liner Systems

E. Ganjian, E. Coakley, S. Abbey, 2021, Sustainability.

Serum miR‐122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR‐122 in HCV‐infected subjects

J. Waring, S. Dutta, E. Coakley, 2016, Journal of viral hepatitis.

Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature.

S. Hammer, B. Taylor, E. Coakley, 2012, AIDS research and human retroviruses.

Assessing Human Immunodeficiency Virus Type 1 Tropism: Comparison of Assays Using Replication-Competent Virus versus Plasma-Derived Pseudotyped Virions

M. Hughes, D. Kuritzkes, C. Flexner, 2009, Journal of Clinical Microbiology.

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

X. Forns, N. Terrault, F. Gordon, 2014 .

P0873 : Ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin (RBV) has minimal impact on health-related quality of life (HRQOL) compared with placebo during 12-week treatment in treatment-naïve adults with chronic Hepatitis C (CHC)

S. Zeuzem, E. Coakley, L. Larsen, 2015 .

Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures

R. Paredes, D. Kuritzkes, Z. Su, 2012, Journal of Virology.

In Vivo Emergence of Vicriviroc Resistance in a Human Immunodeﬁciency Virus Type 1 Subtype C-Infected Subject (cid:1) †

D. Kuritzkes, C. Flexner, Z. Su, 2008 .

Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.

D. Cooper, Naitee Ting, M. Saag, 2010, The Journal of infectious diseases.

A Case-Based Reasoning System for Genotypic Prediction of HIV-1 Co-receptor tropism

Wei Huang, Eoin Coakley, Mark C. Evans, 2013, J. Bioinform. Comput. Biol..

UvA-DARE ( Digital Academic Repository ) Detection of inferred CCR 5-and CXCR 4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing

E. Bunnik, H. Schuitemaker, P. Harrigan, 2011 .

Validation of an enhanced sensitivity Trofile™ HIV-1 co-receptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5

T. Wrin, N. Parkin, J. Larson, 2008 .

DETERMINATION OF VIRAL TROPISM BY GENOTYPING AND PHENOTYPING ASSAYS IN BRAZILIAN HIV-1-INFECTED PATIENTS

E. Coakley, Y. Lie, J. Casseb, 2014, Revista do Instituto de Medicina Tropical de Sao Paulo.

Finite element analysis of the flexural behaviour of steel-reinforced GEM-TECH cementitious material

M. Saidani, E. Coakley, A. Olubanwo, 2018 .

Assessing chemokine co-receptor usage in HIV

Eoin Coakley, C. Petropoulos, J. Whitcomb, 2005, Current opinion in infectious diseases.

Advances in antiretroviral therapy.

S. Hammer, T. Wilkin, E. Coakley, 2003, Topics in HIV medicine : a publication of the International AIDS Society, USA.

Use of Gypsum and CKD to enhance early age strength of High Volume Fly Ash (HVFA) pastes

Eoin Coakley, Dali Bondar, E. Coakley, 2014 .

T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo (cid:1)

M. McCarter, D. N. Levy, E. Connick, 2011 .

The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of ⩽ 50 × 106 cells/l

S. Hammer, M. Samore, E. Coakley, 2000, AIDS (London).

Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.

C. Farthing, A. Zolopa, J. Gallant, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Connection Domain Mutations in HIV-1 Reverse Transcriptase Do Not Impact Etravirine Susceptibility and Virologic Responses to Etravirine-Containing Regimens

R. Paredes, B. Clotet, J. Schapiro, 2011, Antimicrobial Agents and Chemotherapy.

Incorporation of a nanotechnology-based product in cementitious binders for sustainable mitigation of sulphate-induced heaving of stabilised soils

E. Coakley, E. Ganjian, S. Abbey, 2020 .

Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States.

E. Coakley, M. Haddad, J. Vingerhoets, 2011, AIDS Research and Human Retroviruses.

The fat redistribution syndrome in patients infected with HIV: measurements of body shape abnormalities.

E. Coakley, M. Albrecht, C. Wanke, 2001, Journal of the American Dietetic Association.

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

O. Weiland, K. Kowdley, D. Nelson, 2014, The New England journal of medicine.

Serum miR‐122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR‐122 in HCV‐infected subjects

J. Waring, S. Dutta, E. Coakley, 2016, Journal of viral hepatitis.

Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy

B. Masquelier, O. Lambotte, J. Thèze, 2007, AIDS.

Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.

J. Reeves, T. Wilkin, R. Gulick, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization

J. Martinez-Picado, M. Däumer, J. Blanco, 2013, PloS one.

HLA-DR+ CD38+ CD4+ T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo

M. McCarter, D. N. Levy, E. Connick, 2011, Journal of Virology.

Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.

M. Hughes, D. Kuritzkes, C. Flexner, 2009, The Journal of infectious diseases.

Prevalence of genotypic and phenotypic susceptibility to etravirine in US samples received for routine resistance testing

E. Coakley, M. Haddad, J. Vingerhoets, 2010 .